EPI-321
EPI-321-02
Phase 2 mab active
Quick answer
EPI-321 for Facioscapulohumeral Muscular Dystrophy is a Phase 2 program (mab) at Biotech Pharmaceutical Co., with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Biotech Pharmaceutical Co.,
- Indication
- Facioscapulohumeral Muscular Dystrophy
- Phase
- Phase 2
- Modality
- mab
- Status
- active